Arcutis Biotherapeutics, Inc. - COM (ARQT)

Historical Portfolio Holders from Q1 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
128M
Holdings value Q3 2024
$1.2B
Value change Q3 2024
+$14.3M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
185
Number of buys Q3 2024
102
Number of sells Q3 2024
-77
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 128M $1.2B +$14.3M $9.30 186
2024 Q2 127M $1.18B +$10.9M $9.30 185
2024 Q1 125M $1.24B +$284M $9.91 163
2023 Q4 101M $327M +$79.5M $3.23 130
2023 Q3 67.1M $356M -$27.4M $5.31 131
2023 Q2 71.8M $684M -$5.75M $9.53 137
2023 Q1 71.6M $787M +$44.3M $11.00 141
2022 Q4 65.6M $971M +$88.1M $14.80 137
2022 Q3 59.3M $1.13B +$194M $19.11 136
2022 Q2 49.1M $1.05B +$17.6M $21.31 112
2022 Q1 48.3M $930M -$136M $19.26 108
2021 Q4 46.3M $961M -$1.84M $20.74 89
2021 Q3 45.7M $1.09B +$4.81M $23.89 101
2021 Q2 45.5M $1.24B -$38M $27.29 99
2021 Q1 46.8M $1.35B +$170M $28.93 93
2020 Q4 41M $1.15B +$139M $28.13 78
2020 Q3 34.8M $1.02B +$28.9M $29.30 62
2020 Q2 33.8M $1.02B +$33.1M $30.24 55
2020 Q1 32.7M $974M +$973M $29.80 49